On September 15, Tom Sosnoff, Tastylive founder, joined ‘Squawk Box’ on CNBC to discuss the state of the IPO market and what to make of the surge of IPO offerings. Wall Street’s long-anticipated IPO rebound appeared to be firmly underway following a recent surge in sizable public offerings. Sosnoff characterized the current crop of companies as relatively strong and real companies and noted that this vintage is completely different from the surge of SPACs seen in 2021. He suggested these firms had been waiting for the ideal time to go public. He also attributed the strong demand to the attractive pricing for retail investors. However, Sosnoff immediately added a warning and described the market surrounding the new offerings as frothy and the opening numbers as a little bit scary and not that healthy.
Addressing investors who want to get in on the action right away, Sosnoff expressed strong caution. He explained that as an online broker, his firm does not participate in the underwriting process, meaning their customers must buy in the secondary market as soon as trading goes live. He stated that when a stock priced at $32 opens at $110, he would never buy that and suggested that nobody else should either. He noted that many recent stocks are opening at one, two, or three times the IPO price. While he understands that keeping the IPO price low is good for PR, he believes that some retail customers and those attempting to stabilize the stocks are being caught holding the bag.
That being said, we’re here with a list of the 14 best new stocks to buy right now.
Methodology
We sifted through the Finviz stock screener to compile a list of the top companies that went public in the last 2 years. We then selected the 14 stocks that were the most popular among elite hedge funds and that analysts were bullish on. The stocks are ranked in ascending order of the number of hedge funds that have stakes in them, as of Q2 2025.
Note: All data was sourced on September 19.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
14 Best New Stocks to Buy Right Now
14. Concentra Group Holdings Parent Inc. (NYSE:CON)
Number of Hedge Fund Holders: 29
Concentra Group Holdings Parent Inc. (NYSE:CON) is one of the best new stocks to buy right now. On September 18, JPMorgan analyst Benjamin Rossi assumed coverage of Concentra with an Overweight rating and unchanged price target of $31. JPMorgan believes that the current outpatient environment is most favorable for companies with lower reimbursement exposure to federal funding.
Earlier in Q2 2025, Concentra Group ended the quarter with total revenue growth of 15.2% year-over-year. Excluding contributions from the Nova acquisition, the revenue growth was 15.2%. The company’s focus on growth through acquisition and internal development continued. Concentra Group completed the integration and rebranding of Nova occupational health centers and opened an additional de novo site in Chattanooga, Tennessee.
Furthermore, the acquisition of Pivot On-site Health Clinics was completed, which doubled the size of their on-site health clinic segment. The total on-site clinic count is now 240, which is expected to contribute approximately $120 million in revenue for 2025. The company also expanded its board of directors with experienced professionals to contribute to future success. Concentra Group raised its 2025 revenue guidance to a range of $2.13 to $2.16 billion.
Concentra Group Holdings Parent Inc. (NYSE:CON) provides occupational health services in the US. The company offers workers’ compensation, employer & consumer health services, and employer-sponsored primary care services.
13. Amentum Holdings Inc. (NYSE:AMTM)
Number of Hedge Fund Holders: 32
Amentum Holdings Inc. (NYSE:AMTM) is one of the best new stocks to buy right now. On September 18, Morgan Stanley raised the firm’s price target on Amentum to $20 from $19, while keeping an Underweight rating on the shares after fine-tuning the firm’s estimates. Prior to this rating, the company also reported its Q3 2025 earnings results, where Amentum made a revenue of $3.561 billion, which was a 66% increase year-over-year.
This growth was attributed to the combination of Jacobs’ Critical Mission Solutions and Cyber & Intelligence/CMS businesses. The company achieved a net income of $10 million, which was an improvement from a net loss of $26 million year-over-year, with a diluted EPS of $0.04, up from a loss per share of $0.29 in 2024.
A review of segment performance shows that Digital Solutions revenues increased 12% year-over-year to $1.421 billion due to new commercial contract awards, which led to a 21% increase in Adjusted EBITDA to $114 million. Conversely, Global Engineering Solutions’ revenues for the quarter decreased 3% to $2.140 billion due to the expected ramp-down of certain programs. The segment’s Adjusted EBITDA saw a corresponding 2% decrease to $160 million.
Amentum Holdings Inc. (NYSE:AMTM) provides engineering and technology solutions to the US and allied government agencies.
12. CG Oncology Inc. (NASDAQ:CGON)
Number of Hedge Fund Holders: 32
CG Oncology Inc. (NASDAQ:CGON) is one of the best new stocks to buy right now. On September 17, Morgan Stanley raised the firm’s price target on CG Oncology to $79 from $56, while maintaining an Overweight rating on the shares. Earlier in August, CG Oncology announced significant clinical advancements in its bladder cancer pipeline and financial results for Q2 2025.
The company is focused on developing cretostimogene grenadenorepvec, which is an investigational oncolytic immunotherapy for Non-Muscle Invasive Bladder Cancer/NMIBC. Management’s outlook is supported by a strong cash position and a favorable legal outcome that together are expected to fund operations into the first half of 2028.
Clinical trial updates highlighted promising data from the BOND-003 Cohort C trial for high-risk NMIBC patients who are unresponsive to BCG treatment. The company also initiated the CORE-008 Cohort CX trial, which is evaluating the combination of cretostimogene and gemcitabine in high-risk NMIBC patients. Upcoming milestones include the completion of Phase 3 enrollment for the PIVOT-006 trial in Q3 and the initiation of a Biologics License Application submission for cretostimogene in Q4.
CG Oncology Inc. (NASDAQ:CGON) is a late-stage clinical biopharmaceutical company that develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.
11. Slide Insurance Holdings Inc. (NASDAQ:SLDE)
Number of Hedge Fund Holders: 33
Slide Insurance Holdings Inc. (NASDAQ:SLDE) is one of the best new stocks to buy right now. On September 18, Keefe Bruyette upgraded Slide Insurance to Outperform from Market Perform rating with a price target of $19, which was lowered from $20. The company reported a strong performance for Q2 2025, where the total revenue for the quarter increased by 25.1% to $261.6 million due to higher net premiums earned.
The net income saw a rise of 30.5% to $70.1 million, which translated into a diluted EPS of $0.56. Gross premiums written grew 25.0% year-over-year to $435.4 million, which was attributed to the acquisition of additional policies from Citizens and consistent renewal rates. Key factors contributing to the financial results include a positive contribution from net investment income, which rose to $15.0 million from $12.2 million in the prior year.
Slide Insurance Holdings Inc. (NASDAQ:SLDE) engages in underwriting single-family and condominium policies in the property and casualty industry in the US.
10. Voyager Technologies Inc. (NYSE:VOYG)
Number of Hedge Fund Holders: 34
Voyager Technologies Inc. (NYSE:VOYG) is one of the best new stocks to buy right now. On September 14, Voyager Technologies announced the launch of its Space Edge to the International Space Station. The launch marks the first known multi-cloud region in space, representing a breakthrough in real-time, space-based data processing.
Space Edge is a space-hardened, managed cloud infrastructure that extends computing power directly into orbit. The capability is designed to reduce latency, strengthen security, and cut data transport costs for defense, national security, commercial, and in-space research missions where speed and insight are critical.
Developed by LEOcloud, which is a recent Voyager acquisition, Space Edge processes data in orbit, making it up to 30x faster than traditional satellite-to-ground methods by avoiding the latency of transport to a terrestrial data center. By enabling real-time data fusion and analytics at the space edge, Voyager aims to unlock new revenue streams across defense, civil space, and commercial markets.
Voyager Technologies Inc. (NYSE:VOYG) is a defense technology and space solutions company. It operates through 3 segments: Defense & National Security, Space Solutions, and Starlab Space Stations.
9. Solventum Corporation (NYSE:SOLV)
Number of Hedge Fund Holders: 37
Solventum Corporation (NYSE:SOLV) is one of the best new stocks to buy right now. On September 15, Wells Fargo raised the price target on Solventum to $82 from $79, while maintaining an Equal Weight rating on the shares. This sentiment by the firm was posted to reflect the sale of the company’s Purification & Filtration/P&F business. On September 2, Solventum completed the sale of its P&F business to Thermo Fisher Scientific Inc. (NYSE:TMO).
The transaction was finalized for a sale price of $4 billion in cash, before customary adjustments. The divestiture is considered an important step in Solventum’s 3-phased transformation plan, which is aimed at accelerating business transformation and delivering long-term shareholder value.
Following the closing of the transaction, Solventum will continue to provide transitional services and perform certain manufacturing and distribution activities for Thermo Fisher. Looking ahead, Solventum raised its 2025 guidance, projecting organic sales growth of 2-3% and adjusted EPS of $5.80-$5.95.
Solventum Corporation (NYSE:SOLV) is a healthcare company that develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the US and internationally.
8. Marex Group (NASDAQ:MRX)
Number of Hedge Fund Holders: 39
Marex Group (NASDAQ:MRX) is one of the best new stocks to buy right now. On September 9, Barclays analyst Benjamin Budish maintained a Buy rating on Marex Group with a price target of $50. Earlier in August, Marex Group announced very strong financial results for Q2 and H1 2025, with the successful acquisition of the Prime Services business from TD Cowen in late 2023 being a particular highlight.
Marex generated ~$1 billion in H1 revenue, with Q2 revenue increasing 18% year-over-year to make $500.1 million. Agency and Execution revenue increased 59% to $260.8 million due to a strong Securities performance and the ongoing expansion of Prime Services, alongside continued strength in Energy. Clearing revenue increased 12% to $138.8 million due to market volatility, new clients, and the completion of the Aarna Capital Limited acquisition on March 27 this year.
Conversely, Market Making revenue decreased 17% to $57.4 million, as lower revenues in metals compared to a record Q2 2024 more than offset a strong performance in energy. Hedging and Investment Solutions revenue also saw a 9% decrease to $40.7 million as volatility at the start of April 2025 reduced client hedging activity. Marex’s strategic execution included adding geographies and product capabilities.
Marex Group (NASDAQ:MRX) is a financial services platform provider company that provides liquidity, market access, and infrastructure services to clients in the energy, commodities, and financial markets in the UK, the US, and internationally.
7. Hinge Health Inc. (NYSE:HNGE)
Number of Hedge Fund Holders: 47
Hinge Health Inc. (NYSE:HNGE) is one of the best new stocks to buy right now. On September 11, Stifel analyst David Grossman raised the firm’s price target on Hinge Health to $66 from $63, while keeping a Buy rating on the shares. The firm believes that there is significant momentum behind Hinge’s business. In Q2 2025, Hinge Health reported a 55% year-over-year increase in revenue, which reached $139 million.
The company has significantly expanded its network and now has over 50 partners, which include the 5 largest national health plans and the top 3 PBMs. Hinge Health has launched several innovative products to maintain its leadership position. This includes AI-powered motion tracking technology and Hinge Select, which is a high-performance provider network.
The company reported strong client retention rates and a record high member Net Promoter Score/NPS in H1 of the year, driven by a delightful product experience. The CFO noted that by the end of Q2, ~40% of clients had transitioned to a new pay-as-you-go pricing model that includes an upfront platform fee, which holds the company accountable for delivering engaging products and is expected to allow for future increases in Average Selling Price/ASP as record engagement continues.
Hinge Health Inc. (NYSE:HNGE) develops health care software for joint and muscle health. The company designs its platform to address musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation.
6. Waystar Holding Corp. (NASDAQ:WAY)
Number of Hedge Fund Holders: 48
Waystar Holding Corp. (NASDAQ:WAY) is one of the best new stocks to buy right now. On September 16, Waystar reinforced its leadership in AI-powered software by announcing breakthrough innovations at its Fall Innovation Showcase. These advancements, branded Waystar AltitudeAI, are designed to elevate denial prevention and reimbursement recovery, helping providers tackle the financial challenges of $20 billion lost in denial recovery efforts and $17 billion in uncompensated care tied to bad debt.
Waystar’s platform is already delivering over 90% time savings and a 135% lift in pre-service patient collections for early adopters. The new AI-powered solution for denial appeals is the industry’s first scaled, end-to-end offering, allowing mid-size health systems to create hundreds of appeal packages over 90% faster, cutting time from 38 hours to 2, and reallocating the equivalent of 13 full-time employees.
Early adopters are already overturning 40% more denials. For prevention, Waystar AltitudeAI uses insights to address the fact that over 60% of denials are preventable, cutting denial-prevention work from 133 hours to under 6, a 95% time savings. To address uncompensated care, Waystar introduced an advanced pre-service cost estimation capability, which has helped early adopter clients increase pre-service patient payments from 17% to 40% of total payments.
Waystar Holding Corp. (NASDAQ:WAY) develops a cloud-based software solution for healthcare payments. The company’s platform offers financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting solutions.
5. ServiceTitan Inc. (NASDAQ:TTAN)
Number of Hedge Fund Holders: 51
ServiceTitan Inc. (NASDAQ:TTAN) is one of the best new stocks to buy right now. On September 9, Citi analyst Tyler Radke raised the firm’s price target on ServiceTitan to $123 from $111, while keeping a Neutral rating on the shares. The firm updated its application software models following its technology conference. Citi believes that while the sector is not insulated from AI, the worst-case bear concerns are likely overdone.
This sentiment followed the company’s FQ2 2026 earnings report, where ServiceTitan surpassed earnings expectations with a reported Non-GAAP EPS of $0.33 compared to expectations of $0.18. Total revenue for the quarter reached $242.1 million, which was a 25% year-over-year increase due to strength in usage revenue and faster growth from new customers.
Subscription revenue grew 27% year-over-year to $174.8 million, while usage revenue increased 23% year-over-year to $58 million, driven by higher-than-expected Gross Transaction Volume/GTV and a greater mix of on-platform payment solutions. Total platform revenue (subscription plus usage) grew 26% year-over-year to $232.7 million. For its forward guidance, ServiceTitan now anticipates full FY2026 total revenue in the range of $935 to $940 million.
ServiceTitan Inc. (NASDAQ:TTAN) provides an end-to-end cloud-based software platform in the US and Canada. Its platform connects and manages a range of business workflows.
4. Rubrik Inc. (NYSE:RBRK)
Number of Hedge Fund Holders: 52
Rubrik Inc. (NYSE:RBRK) is one of the best new stocks to buy right now. On September 15, Rubrik announced an expanded integration with the CrowdStrike Falcon cybersecurity platform at the Fal.Con 2025 conference in Las Vegas. The integration combines Rubrik Identity Resilience with CrowdStrike Falcon Next-Gen Identity Security to provide a unified identity security solution that enables customers to surgically roll back malicious identity changes and restore identity providers to a secure state.
The core functionality of the integration includes: Real-time identity threat detection and malicious change correlation, where the AI-driven Falcon Next-Gen Identity Security correlates suspicious changes across identity providers/IdPs like Active Directory, Entra ID, and Okta, and Rubrik then ingests these alerts to identify the specific malicious changes.
Following detection, the Surgical rollback of malicious changes is performed by Rubrik Identity Resilience, which recovers and rolls back the malicious actions, using immutability to prevent re-exploitation and offering a full, clean IdP recovery in a worst-case scenario. Finally, the integration offers Accelerated investigation and workflow in the Falcon console by integrating Rubrik Security Cloud with CrowdStrike’s tools, like Falcon Fusion SOAR, Next-Gen SIEM, Falcon Threat Intelligence, and Charlotte AI, which allows security teams to streamline response.
Rubrik Inc. (NYSE:RBRK) provides data security solutions to individuals and businesses worldwide. The company offers a range of solutions like enterprise data protection, unstructured data protection, cloud data protection, and SaaS data protection solutions.
3. Astera Labs Inc. (NASDAQ:ALAB)
Number of Hedge Fund Holders: 56
Astera Labs Inc. (NASDAQ:ALAB) is one of the best new stocks to buy right now. On September 17, Citi raised the price target on Astera Labs to $275 from $160, while keeping a Buy rating. Citi upgraded its estimates to reflect Astera’s AI exposure and a better-than-expected ramp of Scorpio X, which is the company’s new AI product. The firm sees strong earnings growth for Astera in the next 3 years.
Astera announced its Q2 2025 earnings results earlier in August and highlighted record revenue growth driven by its position in the evolving AI infrastructure market. The company reported revenue of $191.9 million, which was an increase of 20% from the prior quarter and 150% year-over-year.
The quarter was fueled by the ramp into volume production of the Scorpio P-Series switches, which support PCIe 6 scale-out applications. This strengthens Astera Labs’ relationships, such as key collaborations with NVIDIA and Alchip Technologies. This then positions the company to capitalize on the AI Infrastructure 2.0 transition, which is an opportunity estimated to be worth an additional $5 billion by 2030.
Astera Labs Inc. (NASDAQ:ALAB) designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure.
2. Maplebear Inc. (NASDAQ:CART)
Number of Hedge Fund Holders: 64
Maplebear Inc. (NASDAQ:CART) is one of the best new stocks to buy right now. On September 16, BTIG analyst Jake Fuller lowered the firm’s price target on Instacart to $55 from $58, while keeping a Buy rating on the shares. Prior to this update, the company reported its Q2 2025 earnings results.
Instacart’s Gross Transaction Value/GTV increased by 11% year-over-year in the said quarter, driven by a 17% growth in total orders. However, the Average Order Value/AOV decreased by 5% year-over-year due to the inclusion of restaurant orders and a lower basket minimum for Instacart+ members.
Total revenue growth was 11% year-over-year, with Transaction Revenue maintaining 7.3% of GTV and Advertising and Other Revenue growing by 12% to represent 2.8% of GTV. The company’s advertising business has reached an annual run rate of over $1 billion, with more than 7,500 active brand partners. Looking ahead to Q3, the company provided guidance expecting GTV to range between $9 and $9.15 billion, which is a projected year-over-year growth of 8% to 10%.
Maplebear Inc. (NASDAQ:CART), doing business as Instacart, provides online grocery shopping services to households in North America through a mobile application or website.
1. Reddit Inc. (NYSE:RDDT)
Number of Hedge Fund Holders: 74
Reddit Inc. (NYSE:RDDT) is one of the best new stocks to buy right now. On September 18, Piper Sandler raised the firm’s price target on Reddit to $290 from $210, while keeping an Overweight rating on the shares following positive Ad Metrics checks. Earlier in Q2 2025, Reddit reported strong financial performance, significantly beating analyst expectations with a diluted EPS of $0.45, compared to the expected $0.20.
Total revenue grew 78% year-over-year to $500 million, which marked the fastest quarterly growth rate since 2022. This growth was driven by a powerful advertising segment, which saw revenue increase by 84% to $465 million. Other revenue, which includes the data licensing business, reached $35 million, up 24%. The Average Revenue Per User grew 47% to $4.53.
The revenue growth was also robust regionally, with the US growing 79% and international markets growing 71%. User and product metrics also showed notable growth and traction. Daily Active Users grew 21% to 110 million, with growth in both the US and international markets. The company’s unique value proposition was highlighted by its status as the #1 most cited domain for AI across all models, validating the essential role of human conversation for LLM and AI search engine training.
Reddit Inc. (NYSE:RDDT) operates a digital community in the US and internationally. The company’s platform enables users to engage in conversations, explore passions, and exchange goods & services.
While we acknowledge the potential of RDDT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than RDDT and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None.
